Dr. Shawna Weis is a highly skilled toxicologist with over 20 years of experience in drug and biologic development, blending her expertise as a pharmaceutical toxicologist and regulator. She has successfully led nonclinical and regulatory toxicology programs for small molecules, biologics, and oligonucleotide therapeutics, spanning all stages of development from discovery through Phase 4.
Dr. Weis's extensive career includes leadership roles at prominent organizations, where she has overseen toxicology studies, regulatory submissions, and strategic program management. With deep expertise in FDA and international regulatory processes, she has guided teams through complex toxicology challenges, contributing to the advancement of innovative therapies across diverse therapeutic areas.
A dedicated mentor and recognized expert in her field, Dr. Weis is an active member of professional societies, including the American College of Toxicology and the Society of Toxicology.